These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35685888)

  • 1. Probiotic Therapy With VSL#3
    Derosa G; Guasti L; D'Angelo A; Martinotti C; Valentino MC; Di Matteo S; Bruno GM; Maresca AM; Gaudio GV; Maffioli P
    Front Nutr; 2022; 9():846873. PubMed ID: 35685888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised placebo controlled trial of VSL#3
    Chong PL; Laight D; Aspinall RJ; Higginson A; Cummings MH
    BMC Gastroenterol; 2021 Apr; 21(1):144. PubMed ID: 33794784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases.
    Chapman TM; Plosker GL; Figgitt DP
    BioDrugs; 2007; 21(1):61-3. PubMed ID: 17263590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.
    Chapman TM; Plosker GL; Figgitt DP
    Drugs; 2006; 66(10):1371-87. PubMed ID: 16903771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Probiotics (MCP
    Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
    Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
    Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Effect of Probiotics on Cytokine Levels in Critically Ill Children With Severe Sepsis: A Double-Blind, Placebo-Controlled Trial.
    Angurana SK; Bansal A; Singhi S; Aggarwal R; Jayashree M; Salaria M; Mangat NK
    Crit Care Med; 2018 Oct; 46(10):1656-1664. PubMed ID: 29957709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relations of hepatic steatosis with liver functions, inflammations, glucolipid metabolism in chronic hepatitis B patients.
    Chen XL; Han YD; Wang H
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5640-5646. PubMed ID: 30229840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
    Wang W; Shi LP; Shi L; Xu L
    Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
    [No Abstract]   [Full Text] [Related]  

  • 10. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
    Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
    Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized Nigella sativa seed oil ameliorates hepatic steatosis, aminotransferase and lipid levels in non-alcoholic fatty liver disease: A randomized, double-blind and placebo-controlled clinical trial.
    Khonche A; Huseini HF; Gholamian M; Mohtashami R; Nabati F; Kianbakht S
    J Ethnopharmacol; 2019 Apr; 234():106-111. PubMed ID: 30639231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3.
    Douillard FP; Mora D; Eijlander RT; Wels M; de Vos WM
    PLoS One; 2018; 13(2):e0192452. PubMed ID: 29451876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of probiotic supplementation on the gut microbiota of preterm infants.
    Plummer EL; Danielewski JA; Garland SM; Su J; Jacobs SE; Murray GL
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431764
    [No Abstract]   [Full Text] [Related]  

  • 14. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.
    Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Mobasseri M; Naghshi S; Ostadrahimi A
    Int J Clin Pract; 2021 Jun; 75(6):e14131. PubMed ID: 33683797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.
    Aller R; De Luis DA; Izaola O; Conde R; Gonzalez Sagrado M; Primo D; De La Fuente B; Gonzalez J
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1090-5. PubMed ID: 22013734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn's disease.
    Fedorak RN; Feagan BG; Hotte N; Leddin D; Dieleman LA; Petrunia DM; Enns R; Bitton A; Chiba N; Paré P; Rostom A; Marshall J; Depew W; Bernstein CN; Panaccione R; Aumais G; Steinhart AH; Cockeram A; Bailey RJ; Gionchetti P; Wong C; Madsen K
    Clin Gastroenterol Hepatol; 2015 May; 13(5):928-35.e2. PubMed ID: 25460016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat germ improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
    Salehi-Sahlabadi A; Kord-Varkaneh H; Kocaadam-Bozkurt B; Seraj SS; Alavian SM; Hekmatdoost A
    Phytother Res; 2022 Nov; 36(11):4201-4209. PubMed ID: 35843540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of intestinal and systemic sequelae of murine
    Ekmekciu I; Fiebiger U; Stingl K; Bereswill S; Heimesaat MM
    Gut Pathog; 2017; 9():17. PubMed ID: 28413453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis.
    Alisi A; Bedogni G; Baviera G; Giorgio V; Porro E; Paris C; Giammaria P; Reali L; Anania F; Nobili V
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1276-85. PubMed ID: 24738701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacteria supplementation: effects on plasma lipid profiles in dyslipidemic children.
    Guardamagna O; Amaretti A; Puddu PE; Raimondi S; Abello F; Cagliero P; Rossi M
    Nutrition; 2014; 30(7-8):831-6. PubMed ID: 24985000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.